Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 74 | +11 |
| Shares | 44.8M | 5.11M | 42.7M | +3.03M (+7.6%) |
| Value | $60.5M | $6.90M | $31.4M | −$22.2M (−41.4%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 4,622,567 | $3.40M | 0.00% |
| Vanguard Fiduciary Trust Co | 455,050 | $334.5K | 0.00% |
| Jane Street Group, LLC | 165,599 | $121.7K | 0.00% |
| Hudson Bay Capital Management LP | 153,331 | $112.7K | 0.00% |
| Cygnus Capital Advisors, LLC | 115,649 | $85.0K | 0.06% |
| Gsa Capital Partners LLP | 96,998 | $71.0K | 0.00% |
| Nine Masts Capital Ltd | 44,849 | $33.0K | 0.01% |
| Diametric Capital, LP | 33,208 | $24.4K | 0.01% |
| Vanguard Global Advisers, LLC | 31,751 | $23.3K | 0.00% |
| CTC Alternative Strategies, Ltd. | 23,622 | $17.4K | 0.04% |
| Brevan Howard Capital Management LP | 23,336 | $17.1K | 0.00% |
| Traphagen Investment Advisors LLC | 22,024 | $16.2K | 0.00% |
| Catalyst Funds Management Pty Ltd | 14,800 | $10.9K | 0.00% |
| Schonfeld Strategic Advisors LLC | 14,200 | $10.4K | 0.00% |
| Bank of New York Mellon Corp | 13,879 | $10.2K | 0.00% |
| Clear Wave Wealth Management LLC | 13,228 | $9.72K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 10,502 | $7.72K | 0.00% |
| Simplex Trading, LLC | 10,101 | $7.42K | 0.00% |
| Federated Hermes, Inc. | 799 | $587 | 0.00% |
Sold out (8)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Virtu Financial LLC | 51,178 | $69.0K |
| Lighthouse Investment Partners, LLC | 42,840 | $57.8K |
| Bank of America Corp | 36,607 | $49.4K |
| Two Sigma Securities, LLC | 35,874 | $48.4K |
| State of Wyoming | 2,076 | $2.80K |
| Advisor Group Holdings, Inc. | 1,000 | $1.35K |
| Elyxium Wealth, LLC | 760 | $1.03K |
| CWM, LLC | 175 | $0 |
Not filed for Q1 2026 yet (1)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 5,109,368 | $6.90M |